BACKGROUND: Because the therapeutic options for managing infections in neonates in developing countries are often limited, innovative approaches to preventing infections are needed. Topical therapy with skin barrier-enhancing products may be an effective strategy for improving neonatal outcomes, particularly among preterm, low birth weight infants whose skin barrier is temporarily but critically compromised as a result of immaturity. METHODS: We tested the impact of topical application of sunflower seed oil 3 times daily to preterm infants <34 weeks gestational age at the Kasr El-Aini neonatal intensive care unit at Cairo University on skin condition, rates of nosocomial infections and mortality. RESULTS: Treatment with sunflower seed oil (n = 51) resulted in a significant improvement in skin condition (P = 0.037) and a highly significant reduction in the incidence of nosocomial infections (adjusted incidence ratio, 0.46; 95% confidence interval, 0.26-0.81; P = 0.007) compared with infants not receiving topical prophylaxis (n = 52). There were no reported adverse events as a result of topical therapy. CONCLUSIONS: Given the low cost (approximately .20 dollars for a course of therapy) and technologic simplicity of the intervention and the effect size observed in this study, a clinical trial with increased numbers of subjects is indicated to evaluate the potential of topical therapy to reduce infections and save newborn lives in developing countries.
RCT Entities:
BACKGROUND: Because the therapeutic options for managing infections in neonates in developing countries are often limited, innovative approaches to preventing infections are needed. Topical therapy with skin barrier-enhancing products may be an effective strategy for improving neonatal outcomes, particularly among preterm, low birth weight infants whose skin barrier is temporarily but critically compromised as a result of immaturity. METHODS: We tested the impact of topical application of sunflower seed oil 3 times daily to preterm infants <34 weeks gestational age at the Kasr El-Aini neonatal intensive care unit at Cairo University on skin condition, rates of nosocomial infections and mortality. RESULTS: Treatment with sunflower seed oil (n = 51) resulted in a significant improvement in skin condition (P = 0.037) and a highly significant reduction in the incidence of nosocomial infections (adjusted incidence ratio, 0.46; 95% confidence interval, 0.26-0.81; P = 0.007) compared with infants not receiving topical prophylaxis (n = 52). There were no reported adverse events as a result of topical therapy. CONCLUSIONS: Given the low cost (approximately .20 dollars for a course of therapy) and technologic simplicity of the intervention and the effect size observed in this study, a clinical trial with increased numbers of subjects is indicated to evaluate the potential of topical therapy to reduce infections and save newborn lives in developing countries.
Authors: Luke C Mullany; Gary L Darmstadt; Joanne Katz; Subarna K Khatry; Steven C LeClerq; Ramesh K Adhikari; James M Tielsch Journal: Am J Epidemiol Date: 2006-10-25 Impact factor: 4.897
Authors: Luke C Mullany; Gary L Darmstadt; Subarna K Khatry; Steve C LeClerq; James M Tielsch Journal: Indian Pediatr Date: 2006-02 Impact factor: 1.411
Authors: James M Tielsch; Gary L Darmstadt; Luke C Mullany; Subarna K Khatry; Joanne Katz; Steven C LeClerq; Shardaram Shrestha; Ramesh Adhikari Journal: Pediatrics Date: 2007-01-08 Impact factor: 7.124
Authors: Gary L Darmstadt; Yoonjoung Choi; Shams E Arifeen; Sanwarul Bari; Syed M Rahman; Ishtiaq Mannan; Habibur Rahman Seraji; Peter J Winch; Samir K Saha; A S M Nawshad Uddin Ahmed; Saifuddin Ahmed; Nazma Begum; Anne C C Lee; Robert E Black; Mathuram Santosham; Derrick Crook; Abdullah H Baqui Journal: PLoS One Date: 2010-03-24 Impact factor: 3.240
Authors: A S M Nawshad Uddin Ahmed; Samir K Saha; M A K Azad Chowdhury; Paul A Law; Robert E Black; Mathuram Santosham; Gary L Darmstadt Journal: J Health Popul Nutr Date: 2007-06 Impact factor: 2.000